Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2017.05.008
Abstract: The majority of persons currently treated for chronic hepatitis B require long-term or lifelong therapy. New inhibitors of hepatitis B virus entry, replication, assembly, or secretion and immune modulatory therapies are in development. The introduction…
read more here.
Keywords:
regulatory approval;
hepatitis;
cure;
discovery regulatory ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Gastroenterologia y hepatologia"
DOI: 10.1016/s0210-5705(20)30181-3
Abstract: Direct-acting antiviral agents are highly potent drugs with a strong genetic barrier. Consequently, the factors influencing hepatitis C cure have been reduced and have progressively lost importance. Host factors, such as the presence of cirrhosis,…
read more here.
Keywords:
treatment;
hepatitis cure;
direct acting;
factors influencing ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Future microbiology"
DOI: 10.2217/fmb-2019-0041
Abstract: Chronic hepatitis C virus (HCV) infection is one of the major causes of death worldwide due to infectious agents. The advent of direct-acting antivirals has dramatically improved the chance of HCV elimination, even for patients…
read more here.
Keywords:
cure antivirals;
hcv;
cure;
antivirals test ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Viruses"
DOI: 10.3390/v11050441
Abstract: Chronic hepatitis C virus (HCV) infection is a major cause of liver disease and hepatocellular carcinoma (HCC)-the second leading, and rising, cause of death due to cancer world-wide [...].
read more here.
Keywords:
hepatocellular carcinoma;
cure persistent;
carcinoma;
challenges hepatitis ... See more keywords